Were you caught up in either of the two AT&T data breaches from 2019 or 2024? If so, you might be eligible for part of a $177 million settlement. According to court documents, the settlement fund ...
Manufacturers have made headway against unplanned downtime. But with parts and labor costs rising and infrastructure aging, every minute offline is more expensive. According to the 2025 State of ...
The National League Wild Card series between the Los Angeles Dodgers and the snuck-in-through-the-back-door Cincinnati Reds begins later today, and both teams have submitted their rosters for the ...
The interest rate cut issued by the Federal Reserve last week may have only lowered the benchmark rate by a quarter of a percentage point, but it inevitably led to a series of questions and ...
PHOENIX — For the first time in nine months, the Federal Reserve has cut its key interest rate, a move that signals a shift toward easing monetary policy. The rate now sits in a range between 4% and 4 ...
After nine months of holding its key interest rate steady, the Federal Reserve is widely expected to announce a rate cut after its two-day September meeting. The central bank’s decision, to be ...
FRANKFURT, Germany — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...
Novo Nordisk, the Danish drugmaker with a large presence in North Carolina, declined to say how many jobs might be cut in the state. But it indicated a planned Triangle expansion might not be affected ...
Novo Nordisk downgraded its guidance for the second time in six weeks as it announced a restructuring plan that will see it cut around 11% of its workforce to save $1.3 billion a year. The move is the ...
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...
Danish pharmaceutical giant Novo Nordisk announced Wednesday that it would cut 11 percent of its workforce, as the maker of Ozempic and Wegovy faces rising competition for its anti-obesity treatments.
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Novo Nordisk, under new leadership and in need of a boost, said ...